Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

Clinical trial NCT00543205 · TERMINATED

Trial details

NCT number: NCT00543205
Sponsor: Genta Incorporated
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Advanced Melanoma and Normal or Impaired Hepatic Function

Start date: 2005-08-01
Primary completion: 2007-05-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.